Transforming health care systems is difficult, and yet that is the goal we are trying to achieve when we are leveraging the technologies of the future to address current health care challenges. And if you're a global multinational, the challenges can be even more complicated. Your day to day can be a mix of conflicting priorities, such as in dealing with the needs of today's business while also keeping an eye on the future, a future which includes health system transformations, personalized health, and health equity. In this episode I speak with Ahmed Elhusseiny, the area head for Roche Pharma in Asia Pacific at their offices in Singapore to discuss how a global multinational can drive change. During this podcast Ahmed and I discuss: The importance of being mission-oriented to address systemic health challenges How Roche’s approach to data-driven healthcare starts with understanding unmet customer needs Examples of Roche’s effectiveness in Public-Private Partnerships The new Economist Whitepaper supported by Roche highlighting APAC’s un-met needs in Breast Cancer About Ahmend Ahmed Elhusseiny has worked in the pharmaceutical industry for nearly 20 years, working across Europe, North America and Asia. He has a strong track record of developing and implementing comprehensive strategies for innovative health therapies. Prior to joining Roche in 2013, he was at Novartis for ten years, where he led various business units, including Ophthalmology and Primary Care. Guest's Links and Resources Connect with Ahmed: LinkedIn Visit Roche Episode PDF Host's Links and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony’s Book: Comatose FutureProofing Healthcare | FutureProofing Healthcare APAC index Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050 Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Special thanks to: Amalgam Rx | Bayer G4A | Lindus Health | LSI